cancer News & Analysis
2 articles
Market Mood
Zai Lab (ZLAB) and Amgen (AMGN) Collaborate on Lung Cancer Therapy
Zai Lab (ZLAB) and Amgen (AMGN) have announced a partnership to evaluate a combination therapy for lung cancer. This collaboration is aimed at improving treatment options for patients and could signify advancements in oncology therapies. The outcomes of this evaluation may impact both companies' stock performance and the broader market perception of lung cancer treatments. Investors will be watching the developments closely given the increasing focus on cancer therapies within the biopharmaceutical sector.
Read More
OpenAI Leadership Changes Announced Amid Medical Leaves for Executives
Fidji Simo, OpenAI's product lead, is taking a medical leave due to Postural Orthostatic Tachycardia Syndrome (POTS) and has announced leadership changes. Simo joined OpenAI in May and cited her health condition's worsening, necessitating several weeks off. In her absence, OpenAI President Greg Brockman will oversee product, with Denise Dresser taking on additional responsibilities. Additionally, Kate Rouch, the marketing chief, is stepping down to focus on her late-stage breast cancer recovery, indicating significant transitions within OpenAI's leadership team.
Read More